ArticleFrontiers in pharmacology2026

Astragaloside IV ameliorates DSS-induced intestinal epithelial barrier dysfunction associated with modulation of tight junction proteins and MLCK/p-MLC and MyD88/TRAF6 signaling pathways.

Mingyue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.